These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 615505)

  • 21. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP
    Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid.
    Schepers GW
    J Int Med Res; 1981; 9(6):511-5. PubMed ID: 7033016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect on uric acid and other laboratory parameters. A long-term study].
    Dorn M
    ZFA (Stuttgart); 1982 Feb; 58(5):296-300. PubMed ID: 7043937
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F
    Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
    Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP
    Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzbromarone therapy in hyperuricaemia.
    Scott WA
    J Int Med Res; 1981; 9(1):82-7. PubMed ID: 7009259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanisms of action of benzbromarone. Study in 3 anephric subjects. Preliminary results in 3 cases].
    Bec Ph; Pujo JM; Suc JM
    Sem Hop Ther; 1977 Apr; 53(4):217-22. PubMed ID: 882865
    [No Abstract]   [Full Text] [Related]  

  • 30. Benzbromarone as a long-term uricosuric agent.
    Bluestone R; Klinenberg J; Lee IK
    Adv Exp Med Biol; 1980; 122A():283-6. PubMed ID: 6999849
    [No Abstract]   [Full Text] [Related]  

  • 31. The action of benzbromarone in relation to age, sex and accompanying diseases.
    Ferber H; Bader U; Matzkies F
    Adv Exp Med Biol; 1980; 122A():287-94. PubMed ID: 6999850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal handling of uric acid in man.
    Levinson DJ; Decker DE; Sorensen LB
    Ann Clin Lab Sci; 1982; 12(1):73-7. PubMed ID: 7065639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A; Giudicelli CP
    Sem Hop Ther; 1976; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract]   [Full Text] [Related]  

  • 35. [The uricosuric effect of benzbromaron and probenecid under fasting conditions (author's transl)].
    Schulz E; Schräpler P; Kleinschmidt A
    Med Klin; 1978 Feb; 73(7):240-6. PubMed ID: 628361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The importance of benziodarone in the treatment of gout and hyperuricemic syndrome].
    Lindusková M; Vykydal M
    Cas Lek Cesk; 1990 Nov; 129(48):1524-5. PubMed ID: 2257602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS; Fox IH
    J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
    Moriwaki Y; Yamamoto T; Takahashi S; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):84-8. PubMed ID: 2307550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
    Masbernard A; Giudicelli CP
    S Afr Med J; 1981 May; 59(20):701-6. PubMed ID: 7221794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Erythrocyte uric acid in the non-gouty subject].
    Asch L; Schirardin H; Weryha A
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):731-2. PubMed ID: 7455606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.